Anders Berggren

405 total citations
23 papers, 296 citations indexed

About

Anders Berggren is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Anders Berggren has authored 23 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Anders Berggren's work include Cardiac electrophysiology and arrhythmias (10 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Cardiac Arrhythmias and Treatments (6 papers). Anders Berggren is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Cardiac Arrhythmias and Treatments (6 papers). Anders Berggren collaborates with scholars based in Sweden, Netherlands and Poland. Anders Berggren's co-authors include Barbara Kniola, S Eneström, Dan Fagrell, Lars Frison, Nils Edvardsson, Mohammad Niazi, Kenneth Egstrup, Håkan Walfridsson, Leif Carlsson and Steen M. Jensen and has published in prestigious journals such as Blood, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Anders Berggren

22 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Berggren Sweden	11	108	96	84	53	33	23	296
Nicoleta Dima Romania	8	60 0.6×	16 0.2×	21 0.3×	58 1.1×	17 0.5×	30	244
Aurélien Philippe France	10	37 0.3×	24 0.3×	34 0.4×	48 0.9×	31 0.9×	28	205
Y Bounameaux Switzerland	9	41 0.4×	20 0.2×	38 0.5×	46 0.9×	102 3.1×	46	283
James Riddel United States	3	51 0.5×	48 0.5×	45 0.5×	31 0.6×	226 6.8×	4	312
Jürgen Sindermann Germany	10	111 1.0×	7 0.1×	96 1.1×	60 1.1×	7 0.2×	33	335
John F. Seymour Switzerland	2	47 0.4×	147 1.5×	6 0.1×	10 0.2×	15 0.5×	2	449
Nicholas Orfan United States	10	20 0.2×	73 0.8×	21 0.3×	15 0.3×	21 0.6×	18	299
Jialin Liang China	10	16 0.1×	7 0.1×	69 0.8×	47 0.9×	16 0.5×	19	272
Myung‐Chul Yoo South Korea	7	23 0.2×	7 0.1×	168 2.0×	31 0.6×	16 0.5×	12	311
Suiqing Huang China	12	158 1.5×	7 0.1×	79 0.9×	79 1.5×	11 0.3×	46	301

Countries citing papers authored by Anders Berggren

Since Specialization

Citations

This map shows the geographic impact of Anders Berggren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Berggren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Berggren more than expected).

Fields of papers citing papers by Anders Berggren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Berggren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Berggren. The network helps show where Anders Berggren may publish in the future.

Co-authorship network of co-authors of Anders Berggren

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Berggren. A scholar is included among the top collaborators of Anders Berggren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Berggren. Anders Berggren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Male, Christoph, et al.. (2025). Anticoagulant prescribing trends, bleeding events, and reversal agent use in pediatric patients: A retrospective, real-world study. PLoS ONE. 20(5). e0323137–e0323137.

Heeney, Matthew M., Miguel R. Abboud, Jessie Githanga, et al.. (2022). Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study. Blood. 140(13). 1470–1481. 11 indexed citations

Niazi, Mohammad, et al.. (2019). Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor. Clinical Drug Investigation. 39(8). 765–773. 4 indexed citations

Heeney, Matthew M., Miguel R. Abboud, Marielle Andersson, et al.. (2019). Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3). Contemporary Clinical Trials. 85. 105835–105835. 6 indexed citations

Niazi, Mohammad, et al.. (2019). Population Pharmacokinetics/Pharmacodynamics of Ticagrelor in Children with Sickle Cell Disease. Clinical Pharmacokinetics. 58(10). 1295–1307. 10 indexed citations

Edman, K. A. P., Mahdi Hashemi, Eva-Marie Andersson, et al.. (2019). Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials. The Lancet Rheumatology. 2(1). e31–e41. 17 indexed citations

Hsu, Lewis L., et al.. (2018). A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study. American Journal of Hematology. 93(12). 1493–1500. 14 indexed citations

Balendran, Clare A., Ann Lövgren, Kenny M. Hansson, et al.. (2017). Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 25(1). 30–30. 11 indexed citations

Jeppsson, Anders, Sven Nylander, Anders Berggren, et al.. (2015). In vitro anti-platelet potency of ticagrelor in blood samples from infants and children. Thrombosis Research. 136(3). 620–624. 10 indexed citations

10.

Walfridsson, Håkan, Anders Berggren, Lars Frison, et al.. (2014). Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans. EP Europace. 17(3). 473–482. 31 indexed citations

11.

Egstrup, Kenneth, Lars Frison, Anders Berggren, et al.. (2013). Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation. Journal of Electrocardiology. 47(3). 316–323. 6 indexed citations

12.

Edvardsson, Nils, et al.. (2012). Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009. Journal of Electrocardiology. 46(1). 29–35. 10 indexed citations

13.

Dota, Corina, Leif Carlsson, Lars Frison, et al.. (2012). Assessment of Ventricular Repolarization Variability with the DeltaT50 Method Improves Identification of Patients with Congenital Long QT Syndromes. Annals of Noninvasive Electrocardiology. 18(3). 240–250. 3 indexed citations

14.

Egstrup, Kenneth, Lennart Bergfeldt, Lars Gullestad, et al.. (2011). QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation. American Journal of Cardiovascular Drugs. 11(3). 199–208. 1 indexed citations

15.

Dota, Corina, Lena Carlsson, Lars Frison, et al.. (2011). DeltaT50—a new method to assess temporal ventricular repolarization variability. Journal of Electrocardiology. 44(4). 477.e1–477.e9. 5 indexed citations

16.

Alings, Marco, Kenneth Egstrup, Zbigniew Gaciong, et al.. (2011). Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously. EP Europace. 13(8). 1148–1156. 9 indexed citations

17.

Toivonen, Lauri, Pekka Raatikainen, Håkan Walfridsson, et al.. (2010). A Randomized Invasive Cardiac Electrophysiology Study of the Combined Ion Channel Blocker AZD1305 in Patients After Catheter Ablation of Atrial Flutter. Journal of Cardiovascular Pharmacology. 56(3). 300–308. 6 indexed citations

18.

Geller, J. Christoph, Kenneth Egstrup, Piotr Kułakowski, et al.. (2009). Rapid Conversion of Persistent Atrial Fibrillation to Sinus Rhythm by Intravenous AZD7009. The Journal of Clinical Pharmacology. 49(3). 312–322. 22 indexed citations

19.

Önning, G., et al.. (2003). Influence of a drink containing different antioxidants andLactobacillus plantarum299v on plasma total antioxidant capacity, selenium status and faecal microbial flora. International Journal of Food Sciences and Nutrition. 54(4). 281–289. 12 indexed citations

20.

Fagrell, Dan, S Eneström, Anders Berggren, & Barbara Kniola. (1996). Fat Cylinder Transplantation: An Experimental Comparative Study of Three Different Kinds of Fat Transplants. Plastic & Reconstructive Surgery. 98(1). 90–96. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact